Tackling the emerging threat of antifungal resistance to human health

MC Fisher, A Alastruey-Izquierdo, J Berman… - Nature reviews …, 2022 - nature.com
Invasive fungal infections pose an important threat to public health and are an under-
recognized component of antimicrobial resistance, an emerging crisis worldwide. Across a …

Bloodstream infections in critically ill patients: an expert statement

JF Timsit, E Ruppé, F Barbier, A Tabah… - Intensive care medicine, 2020 - Springer
Bloodstream infection (BSI) is defined by positive blood cultures in a patient with systemic
signs of infection and may be either secondary to a documented source or primary—that is …

Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial

TMJ Ewoldt, A Abdulla, WJR Rietdijk, AE Muller… - Intensive Care …, 2022 - Springer
Purpose Individualising drug dosing using model-informed precision dosing (MIPD) of beta-
lactam antibiotics and ciprofloxacin has been proposed as an alternative to standard dosing …

Rationalizing antimicrobial therapy in the ICU: a narrative review

JF Timsit, M Bassetti, O Cremer, G Daikos… - Intensive care …, 2019 - Springer
The massive consumption of antibiotics in the ICU is responsible for substantial ecological
side effects that promote the dissemination of multidrug-resistant bacteria (MDRB) in this …

[HTML][HTML] Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives

F de Velde, JW Mouton, BCM de Winter… - Pharmacological …, 2018 - Elsevier
Because of increasing antimicrobial resistance and the shortage of new antibiotics, there is
a growing need to optimize the use of old and new antibiotics. Modelling of the …

Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM …

JJ De Waele, M Akova, M Antonelli, R Canton… - Intensive care …, 2018 - Springer
Antimicrobial resistance (AMR) is a clear and present danger to patients in any intensive
care unit (ICU) around the world. Whereas AMR may affect any patient in the hospital …

The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre …

A Abdulla, TMJ Ewoldt, NGM Hunfeld, AE Muller… - BMC infectious …, 2020 - Springer
Background Critically ill patients undergo extensive physiological alterations that will have
impact on antibiotic pharmacokinetics. Up to 60% of intensive care unit (ICU) patients meet …

Model‐informed drug development for anti‐infectives: state of the art and future

CR Rayner, PF Smith, D Andes… - Clinical …, 2021 - Wiley Online Library
Model‐informed drug development (MIDD) has a long and rich history in infectious
diseases. This review describes foundational principles of translational anti‐infective …

Isavuconazole therapeutic drug monitoring in critically ill ICU patients: a monocentric retrospective analysis

R Höhl, R Bertram, M Kinzig, GS Haarmeyer… - Mycoses, 2022 - Wiley Online Library
Background The broad‐spectrum triazole isavuconazole is used for the treatment of invasive
aspergillosis and mucormycosis. Data regarding human plasma concentrations in clinical …

Pharmacokinetics and target attainment of antibiotics in critically ill children: a systematic review of current literature

SJF Hartman, RJ Brüggemann, L Orriëns, N Dia… - Clinical …, 2020 - Springer
Background Pharmacokinetics (PK) are severely altered in critically ill patients due to
changes in volume of distribution (Vd) and/or drug clearance (Cl). This affects the target …